ArticleNeurobiology of disease2013

Somatostatin type-2 receptor activation inhibits glutamate release and prevents status epilepticus.

Maxim Kozhemyakin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.